EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico design and validation of high-affinity RNA aptamers for SARS-CoV-2 comparable to neutralizing antibodies

Yanqing Yang iD, Lulu Qiao, Yangwei Jiang, Zhiye Wang iD, Dong Zhang iD, Damiano Buratto, Liquan Huang iD, Ruhong Zhou

eLife · 14.07.2026 · 14

DOI: 10.7554/elife.107785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 14.07.2026. Verfasst von Yanqing Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Quantitative Biology, College of Life Sciences, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleic acid aptamers hold promise for clinical applications, yet understanding their molecular binding mechanisms to target proteins, and efficiently optimizing their binding affinities, remain challenging. Here, we present CAAMO ( C omputer- A ided A ptamer M odeling and O ptimization), which integrates in silico aptamer design with experimental validation to accelerate the development of aptamer-based RNA therapeutics. Starting from the sequence information of a reported RNA aptamer, Ta, for the SARS-CoV-2 spike protein, our CAAMO method first determines its binding mode with the spike protein’s receptor binding domain (RBD) through a multi-strategy computational approach. We then optimize its binding affinity via structure-based rational design. Among the six designed candidates, five were experimentally verified and exhibited enhanced binding affinities compared to the original Ta sequence. Furthermore, we directly compared the binding properties of the RNA aptamers to neutralizing antibodies and found that the designed aptamer Ta G34C demonstrated a comparable binding affinity to the RBD compared to the representative neutralizing antibodies analyzed in this study. This highlights its potential as an alternative to existing COVID-19 antibodies. Our work provides a robust approach for the efficient design of a relatively large number of high-affinity aptamers with complicated topologies. This approach paves the way for the development of aptamer-based RNA diagnostics and therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideSARS-CoV-2Computer SimulationAntibodies, NeutralizingModels, ChemicalHumansSpike Glycoprotein, CoronavirusProtein BindingCOVID-19

Stichwörter der Autor:innen

RNA aptamerSARS-CoV-2electrophoretic mobility shift assaymolecular biophysicsmolecular dynamicsnonerational designstructural biology

Substanzen

Aptamers, NucleotideAntibodies, NeutralizingSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Institute of Quantitative Biology, College of Life Sciences, Zhejiang University, Hangzhou, China.
  • State Key Laboratory of Plant Environmental Resilience, College of Life Sciences, Zhejiang University, HangZhou, China.
  • The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

ORCID-Profile: Yanqing Yang, Zhiye Wang, Dong Zhang, Liquan Huang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation of China
  • National Independent Innovation Demonstration Zone Shanghai Zhangjiang Major Projects
  • Starry Night Science Fund at Shanghai Institute for Advanced Study of Zhejiang University
  • National Center of Technology Innovation for Biopharmaceuticals
  • Shanghai Artificial Intelligence Lab
  • Zhejiang University Global Partnership Fund

Zitieren

APA

Yang, Y., Qiao, L., Jiang, Y., Wang, Z., Zhang, D., Buratto, D., Huang, L., & Zhou, R. (2026). In silico design and validation of high-affinity RNA aptamers for SARS-CoV-2 comparable to neutralizing antibodies. eLife, 14. https://doi.org/10.7554/elife.107785

Vancouver

Yang Y, Qiao L, Jiang Y, Wang Z, Zhang D, Buratto D, et al. In silico design and validation of high-affinity RNA aptamers for SARS-CoV-2 comparable to neutralizing antibodies. eLife. 2026;14. doi:10.7554/elife.107785

BibTeX
@article{Yang2026,
  author = {Yang, Yanqing and Qiao, Lulu and Jiang, Yangwei and Wang, Zhiye and Zhang, Dong and Buratto, Damiano and Huang, Liquan and Zhou, Ruhong},
  title = {In silico design and validation of high-affinity RNA aptamers for SARS-CoV-2 comparable to neutralizing antibodies},
  journal = {eLife},
  year = {2026},
  volume = {14},
  doi = {10.7554/elife.107785}
}
Kostenlos starten →